Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Flister

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Trends in Cancer|June 5, 2018
Genetic Modifiers of the Breast Tumor MicroenvironmentMichael J Flister, Carmen Bergom
Microcirculation (New York, N.Y. : 1994)|December 21, 2010
Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κBMichael J Flister, Lisa D Volk, Sophia Ran
Pathophysiology : the Official Journal of the International Society for Pathophysiology|December 29, 2009
Lymphangiogenesis and lymphatic metastasis in breast cancerSophia Ran, Lisa Volk, Kelly Hall, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2019
Mapping Mammary Tumor Traits in the RatMichael J Flister, Amit Joshi, Carmen Bergom, et al.
Plos One|March 8, 2012
New model of macrophage acquisition of the lymphatic endothelial phenotypeKelly L Hall, Lisa D Volk-Draper, Michael J Flister, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2023
NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancerCody Plasterer, Marharyta Semenikhina, Shirng-Wern Tsaih, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
Congenic mapping and sequence analysis of the Renin locusMichael J Flister, Matthew J Hoffman, Prajwal Reddy, et al.
Elife|May 30, 2018
mTORC1 and mTORC2 differentially promote natural killer cell developmentChao Yang, Shirng-Wern Tsaih, Angela Lemke, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastasesLisa D Volk, Michael J Flister, Deena Chihade, et al.
Journal of Cardiovascular Translational Research|April 30, 2015
2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular ResearchMichael J Flister, Jeremy W Prokop, Jozef Lazar, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Trends in Cancer|June 5, 2018
Genetic Modifiers of the Breast Tumor MicroenvironmentMichael J Flister, Carmen Bergom
Microcirculation (New York, N.Y. : 1994)|December 21, 2010
Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κBMichael J Flister, Lisa D Volk, Sophia Ran
Pathophysiology : the Official Journal of the International Society for Pathophysiology|December 29, 2009
Lymphangiogenesis and lymphatic metastasis in breast cancerSophia Ran, Lisa Volk, Kelly Hall, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2019
Mapping Mammary Tumor Traits in the RatMichael J Flister, Amit Joshi, Carmen Bergom, et al.
Plos One|March 8, 2012
New model of macrophage acquisition of the lymphatic endothelial phenotypeKelly L Hall, Lisa D Volk-Draper, Michael J Flister, et al.
Molecular Medicine (Cambridge, Mass.)|July 3, 2023
NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancerCody Plasterer, Marharyta Semenikhina, Shirng-Wern Tsaih, et al.
Hypertension (Dallas, Tex. : 1979)|March 6, 2013
Congenic mapping and sequence analysis of the Renin locusMichael J Flister, Matthew J Hoffman, Prajwal Reddy, et al.
Elife|May 30, 2018
mTORC1 and mTORC2 differentially promote natural killer cell developmentChao Yang, Shirng-Wern Tsaih, Angela Lemke, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastasesLisa D Volk, Michael J Flister, Deena Chihade, et al.
Journal of Cardiovascular Translational Research|April 30, 2015
2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular ResearchMichael J Flister, Jeremy W Prokop, Jozef Lazar, et al.
Pageof 6